USD 1.35
(4.65%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -7.05 Million USD | 74.82% |
2022 | -28 Million USD | -163.58% |
2021 | -10.62 Million USD | -14.3% |
2020 | -9.29 Million USD | 70.94% |
2019 | -31.99 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -646 Thousand USD | 63.04% |
2024 Q1 | -1.74 Million USD | -1521.14% |
2023 Q1 | -4.94 Million USD | 12.56% |
2023 FY | -7.05 Million USD | 74.82% |
2023 Q3 | -1.47 Million USD | -96.4% |
2023 Q2 | -751 Thousand USD | 84.82% |
2023 Q4 | 123 Thousand USD | 108.34% |
2022 Q1 | 2.95 Million USD | 165.86% |
2022 Q4 | -5.65 Million USD | 6.18% |
2022 Q3 | -6.03 Million USD | 31.99% |
2022 FY | -28 Million USD | -163.58% |
2022 Q2 | -8.86 Million USD | -400.44% |
2021 FY | -10.62 Million USD | -14.3% |
2021 Q4 | -4.48 Million USD | -16.87% |
2021 Q3 | -3.83 Million USD | -215.9% |
2021 Q2 | -1.21 Million USD | -10.97% |
2021 Q1 | -1.09 Million USD | -13.37% |
2020 Q4 | -965 Thousand USD | -529.77% |
2020 Q3 | -153.23 Thousand USD | -3.02% |
2020 Q1 | 376.33 Thousand USD | 0.0% |
2020 Q2 | -148.73 Thousand USD | -139.52% |
2020 FY | -9.29 Million USD | 70.94% |
2019 Q3 | - USD | 0.0% |
2019 FY | -31.99 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
CannBioRx Life Sciences Corp. | -13.47 Million USD | 47.683% |
BIMI International Medical Inc. | -15.33 Million USD | 54.031% |
China Jo-Jo Drugstores, Inc. | -3.53 Million USD | -99.487% |
Harrow Health, Inc. 8.625% Senior Notes due 2026 | 580 Thousand USD | 1315.69% |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 431 Thousand USD | 1735.963% |
Leafly Holdings, Inc. | -7.05 Million USD | -0.0% |
LifeMD, Inc. | -14.48 Million USD | 51.336% |
LifeMD, Inc. | -14.48 Million USD | 51.336% |
TRxADE HEALTH, Inc. | -7.26 Million USD | 2.924% |
PetMed Express, Inc. | -8.16 Million USD | 13.612% |
Walgreens Boots Alliance, Inc. | -14.07 Billion USD | 99.95% |